Search
image5
ホームページ製品会社概要ニュースお問い合わせ
Notice of Annual General Meeting in CellaVision AB (publ), April 29, 2010
2010-03-26
English
* { font-family: Arial, Verdana, Helvetica; font-size: 13px;} td { padding: 3px; } }

The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on Thursday April 29, 2010 at 17.00 at CellaVision AB, Scheelevägen 19 A, Ideon, in Lund, Sweden.


The complete notice is available in Swedish only, please click the link below.


For more information, please contact:
Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82, e-mail:
yvonne.martensson@cellavision.se 
Johan Wennerholm, CFO. Phone: +46 708 33 81 68, e-mail:
johan.wennerholm@cellavision.se


About CellaVision
CellaVision AB develops, markets, and sells market leading image analysis based systems for routine analysis of blood and other body fluids. The company has a core competence in development of software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company's associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy.
 
The company headquarters are in Lund, Sweden. The company also has subsidiaries in the US, Canada and Japan. For more information, visit
www.cellavision.com.
 
CellaVision's share is listed on First North Premier at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.


Notice of Annual General Meeting in CellaVision AB (in Swedish)
Archive